Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02009176Not ApplicableUnknown

Laparoscope Anatomical and Aon-anatomical Hepatectomy

Role: lead

NCT02203409Unknown

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Role: lead

NCT01567631Not ApplicableUnknown

Classical Procedure Versus Intrahepatic Glisson's Approach

Role: lead

NCT02014025Not ApplicableCompleted

Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC

Role: lead

NCT01563510Not ApplicableUnknown

Research of the Key Technology and Standardization of Minimal Invasive Treatment for Hepatolithiasis

Role: lead

All 5 trials loaded